bezafibrate has been researched along with Allergic Encephalomyelitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellen, HJ; Chung, HL; Kanca, O; Lee, HK; Lu, S; Mok, JW; Park, YJ; Perrimon, N; Tattikota, SG; Ye, Q; Zuo, Z | 1 |
| Buonvicino, D; Chiarugi, A; Guasti, D; Pratesi, S; Ranieri, G | 1 |
2 other study(ies) available for bezafibrate and Allergic Encephalomyelitis
| Article | Year |
|---|---|
Very-long-chain fatty acids induce glial-derived sphingosine-1-phosphate synthesis, secretion, and neuroinflammation.
Topics: Animals; Bezafibrate; Encephalomyelitis, Autoimmune, Experimental; Fatty Acids; Fingolimod Hydrochloride; Immunosuppressive Agents; Mice; Multiple Sclerosis; Neuroglia; Neuroinflammatory Diseases; Propylene Glycols | 2023 |
Neuroimmunological characterization of a mouse model of primary progressive experimental autoimmune encephalomyelitis and effects of immunosuppressive or neuroprotective strategies on disease evolution.
Topics: Animals; Bezafibrate; Biotin; Dexamethasone; Encephalomyelitis, Autoimmune, Experimental; Immunosuppressive Agents; Mice; Mice, Inbred NOD; Mitochondria; Multiple Sclerosis, Chronic Progressive; Neuroprotective Agents; Spinal Cord | 2019 |